{"id":"W2536396512","doi":"10.1016/s1470-2045(16)30508-3","title":"Osimertinib for pretreated EGFR Thr790Met-positive advanced non-small-cell lung cancer (AURA2): a multicentre, open-label, single-arm, phase 2 study","year":2016,"lang":"en","type":"article","venue":"The Lancet Oncology","topic":"Lung Cancer Treatments and Mutations","field":"Medicine","cited_by":643,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of Alberta; Princess Margaret Cancer Centre; University of Ottawa; Ottawa Hospital","funders":"National Cancer Institute; AstraZeneca","keywords":"Osimertinib; Lung cancer; Medicine; Open label; Cancer; Oncology; Internal medicine; Adenocarcinoma; Clinical trial","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"codex-gemma-dda1882f352a","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.0002899945,0.0003004284,0.0008288603,0.00006545162,0.0002620687,0.00003291011,0.000380403,0.0001131544,0.0002209092],"category_scores_gemma":[0.000104655,0.0001590921,0.00006806381,0.000223886,0.0001140625,0.0001492713,0.0001416532,0.0001517541,0.00002681182],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0009073223,"about_ca_system_score_gemma":0.0005248894,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.0003757329,"about_ca_topic_score_gemma":0.0004342368,"domain_scores_codex":[0.9981059,0.0001871259,0.0003962126,0.0005374667,0.0001495447,0.0006236819],"domain_scores_gemma":[0.9979934,0.0006895262,0.0002975699,0.0005575694,0.0002992473,0.0001626951],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"design_other","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.04916632,0.08704337,0.05548121,0.0004343129,0.007315743,0.0004341015,0.02535572,0.0000543868,0.1803924,0.0003490316,0.0249066,0.5690668],"study_design_scores_gemma":[0.7143987,0.06837609,0.01912476,0.001299872,0.01326909,0.00007615656,0.005322096,0.00233491,0.06395339,0.0002106853,0.1103705,0.001263748],"study_design_candidate":"randomized_trial","study_design_consensus":null,"genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9651523,0.001376153,0.001128864,0.00899554,0.0006565645,0.01068486,0.0004654779,0.0001141647,0.01142614],"genre_scores_gemma":[0.9860511,0.0002440882,0.002633173,0.002522177,0.0004469859,0.003326079,0.000063111,0.0000646687,0.004648625],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.6652324,"threshold_uncertainty_score":0.6487586,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.06472232217388303,"score_gpt":0.4461270129553907,"score_spread":0.3814046907815077,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}